Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences.

Hutchinson AB, Farnham PG, Dean HD, Ekwueme DU, del Rio C, Kamimoto L, Kellerman SE.

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):451-7.

PMID:
16980906
2.

Economic costs of diabetes in the U.S. In 2007.

American Diabetes Association.

Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271.

PMID:
18308683
3.

The estimated direct medical cost of sexually transmitted diseases among American youth, 2000.

Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL.

Perspect Sex Reprod Health. 2004 Jan-Feb;36(1):11-9. Review.

PMID:
14982672
4.

Economic impact of HIV.

Veenstra N, Whiteside A.

Best Pract Res Clin Obstet Gynaecol. 2005 Apr;19(2):197-210. Epub 2004 Dec 13. Review.

PMID:
15778110
5.

The economic impact of schizophrenia.

Rice DP.

J Clin Psychiatry. 1999;60 Suppl 1:4-6; discussion 28-30. Review.

6.

Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature.

Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J.

COPD. 2006 Dec;3(4):211-8. Review.

PMID:
17361502
7.

Combining prevention, treatment and care: lessons from South Africa.

Achmat Z, Simcock J.

AIDS. 2007 Jul;21 Suppl 4:S11-20. Review.

PMID:
17620746
8.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
9.
10.

Socio-economic impact of antiretroviral treatment in HIV patients. An economic review of cost savings after introduction of HAART.

Gonzalo T, García Goñi M, Muñoz-Fernández MA.

AIDS Rev. 2009 Apr-Jun;11(2):79-90. Review.

PMID:
19529748
11.

[Cost of HIV treatment in highly active antiretroviral therapy in Japan].

Kimura H.

Nihon Rinsho. 2002 Apr;60(4):813-6. Review. Japanese.

PMID:
11968794
12.

Costs associated with combination antiretroviral therapy in HIV-infected patients.

Yazdanpanah Y.

J Antimicrob Chemother. 2004 Apr;53(4):558-61. Epub 2004 Feb 25. Review.

PMID:
14985277
13.

Defining and measuring the costs of the HIV epidemic to business firms.

Farnham PG.

Public Health Rep. 1994 May-Jun;109(3):311-8. Review.

14.

HAART, adherence, and cultural issues in the US Latino community.

Santos G, Puga AM, Medina C.

AIDS Read. 2004 Oct;14(10 Suppl):S26-9. Review.

PMID:
15497221
15.

How good are US studies of HIV costs of care?

Rabeneck L, Menke T, Wray NP.

Med Care. 1999 Aug;37(8):748-59. Review.

PMID:
10448718
16.
17.

The economic cost of migraine. Present state of knowledge.

de Lissovoy G, Lazarus SS.

Neurology. 1994 Jun;44(6 Suppl 4):S56-62. Review.

PMID:
8008226
18.

The geographic distribution of AIDS in the United States: is there a rural epidemic?

Steinberg S, Fleming P.

J Rural Health. 2000 Winter;16(1):11-9. Review.

PMID:
10916311
19.

The lifetime cost of current human immunodeficiency virus care in the United States.

Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR 3rd, Moore RD, Freedberg KA.

Med Care. 2006 Nov;44(11):990-7. Review.

PMID:
17063130
20.

Supplemental Content

Support Center